The annual Interchange brings together policymakers, pharmaceutical manufacturers, patient advocates, law enforcement, healthcare professionals, and anti-counterfeiting companies to discuss the problem and solutions to the global scourge of pharmaceutical counterfeiting.
7:30 a.m. - 8:30 a.m. Pre-conference breakfast, sponsor table browsing and networking.
8:30 a.m. - Conference opener
Introduction - Scott LaGanga, Executive Director Partnership for Safe Medicines; Vice President, Public Affairs - Advocacy, Pharmaceutical Research and Manufacturers of America (PhRMA)
8:40 a.m. - 9:10 a.m. Research Presentations
- Tim K. Mackey, PhD, Assistant Professor, University of California, School of Medicine, Department of Anesthesiology - Clear and Present Danger: Availability of Dangerous, Unapproved and Recalled Drugs Online.
- Theodore J. Cicero, PhD, Professor, Vice Chairman for Research at Washington University in St. Louis, Department of Psychiatry – Health outcomes in patients using no-prescription online pharmacies to purchase prescription drugs.
9:10 – 10:30 a.m. Panel 1: How Have American Patients Been Impacted by Counterfeit Medicines?
Moderator: Scott Williams, Director, American Cancer Society Cancer Action Network
Moderator will provide 20 minute overview of the ways patient consequences of counterfeit and non-FDA approved medicines found in circulation in 2012-2013. Among the topics covered will be Avastin, osteoporosis drugs, Botox, Adderall, stolen goods re-sold into legitimate pharmacies, fake online pharmacies, myths and lies that convince consumers to purchase from non-FDA approved sources. Panel discussion to focus on the major ways patient groups have been impacted by these events.
- William E. Arnold, CEO and Vice-Chair, Community Access National Network (PSM member)
- Christopher Weaver, Health & Science Reporter, The Wall Street Journal
- Suzanne Willard, President-Elect, Association of Nurses in AIDS Care (PSM member)
10:30 a.m. - 10:45 a.m. Networking Break
10:45 a.m. - 12:05 p.m. Panel 2: Overview of Fake Online Pharmacy Issues
Moderator: Dr. Bryan Liang
Moderator will provide 20 minute overview of the current status of fake online pharmacies - influence of social media, ease of creation, depth of organized crime involvement, linked to health risks caused by fake medications. Discuss FDA warnings to websites for selling counterfeit and mis-branded medications and the patient safety risks. Panel discussion to focus on the various risks involved from fake online pharmacies.
- Amelia Arnold, Pharm.D., Clinical Pharmacist, Community Pharmacies, Maine
- Special Agent Daniel Burke, Senior Operations Manager in Charge of Cybercrime Investigations for FDA-OCI
- Elizabeth Scott Russell, Government Affairs Manager, National Association of Boards of Pharmacy
12:05 p.m. - 1:15 p.m. Luncheon
Luncheon Speaker: Bejon Misra, Partnership for Safe Medicines India
1:15 p.m. - 2:35 p.m. Panel 3: Bringing Criminals to Justice Across Jurisdictions
Moderator: Chuck Forsaith, Corporate Director, Supply Chain Security, Purdue Pharma Technologies, Inc.
Moderator to provide 20 minute overview of the recent history of medicine counterfeiting crime in the US. Panel to discuss recent closed cases.
- Trial Attorney Roger Gural, Department of Justice, Consumer Protection Branch
- Assistant US Attorney Sam Louis, Deputy Chief Program Fraud Division
- Jeremy Pierczynski, Pharmaceuticals Program Manager, DHS/ICE/Homeland Security Investigations National IPR Coordination Center
2:35 p.m. - 3:35 p.m. Panel 4: Overview of New Developments in International Cooperation
Moderator: Linda Marks, Senior Litigation Counsel of the Consumer Protection Branch of the U.S. Department of Justice
Moderator to provide 15 minute overview of the impact of counterfeit medications worldwide, highlighting the impact the world counterfeiting problem has on Americans. Panel discussion will focus on new developments in international cooperation to fight counterfeit medicines.
- Scott Ballman, Technical Expert for IP Program - North America, World Customs Organization
- Dr. Patrick Lukulay, Vice President of Global Health Impact Programs at USP and Director of the USAID Promoting the Quality of Medicines Program
- John Roth, Director U.S. Food and Drug Administration Office of Criminal Investigations
3:35 p.m. - 4:00 p.m. Keynote Speaker: Dr. Ilisa Bernstein, Deputy Director of the Office of Compliance in the Center for Drug Evaluation and Research (FDA)
4:00 p.m. - 4:15 p.m. Session TBD
4:15 p.m. - 4:17 p.m. Closing Remarks - Scott LaGanga
4:17 p.m. - 5:15 p.m. Reception
Note: Agenda subject to change